Shintaku, Ichiro, Satoh, Makoto, Okajima, Eijiro, Fujimoto, Hiroyuki, Kamoto, Toshiyuki, Ogawa, Osamu, ...
Background As a risk classification system of metastatic germ cell tumors, the International Germ Cell Consensus (IGCC) classification was proposed in 1997 and has received broad approval. Since the...
Shimazui, Toru, Kawai, Koji, Miyanaga, Naoto, Kojima, Takahiro, Sekido, Noritoshi, Hinotsu, Shiro, ...
Background We previously reported that weekly treatment with docetaxel alone is useful for and well tolerated by patients with hormone-refractory prostate cancer (HRPC). Here, we compare it with the...
Miyanaga, Naoto, Akaza, Hideyuki, Hinotsu, Shiro, Joraku, Akira, Oikawa, Takehiro, Sekido, Noritoshi, ...
Objective The present study was undertaken to identify the patients suitable for bladder preservation by analysis of our data. Methods The subjects of this study were all 72 patients with T2–3N0M0...
Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...
Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...
Background Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...
Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...
Takaoka, Ei-Ichiro, Kawai, Koji, Ando, Satoshi, Shimazui, Toru, Akaza, Hideyuki
A 54-year-old man received combination chemotherapy with nedaplatin and irinotecan as salvage chemotherapy for refractory non-seminomatous testicular cancer. The patient developed abdominal pain and...
Takaoka, Ei-Ichiro, Kawai, Koji, Ando, Satoshi, Shimazui, Toru, Akaza, Hideyuki
A 54-year-old man received combination chemotherapy with nedaplatin and irinotecan as salvage chemotherapy for refractory non-seminomatous testicular cancer. The patient developed abdominal pain and...
Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...
Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...
Kawai, Koji, Takaoka, Ei-Ichiro, Naoi, Makito, Mori, Kensaku, Minami, Manabu, Shimazui, Toru, ...
A 26-year-old man was referred to our hospital for treatment of metastatic testicular cancer. The pathological diagnosis was choriocarcinoma with seminoma. Sequential computerized tomography...
Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...
Background: Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...
Kojima, Takahiro, Shimazui, Toru, Onozawa, Mizuki, Tsukamoto, Sadamu, Hinotsu, Shiro, Miyanaga, Naoto, ...
Objective: Although treatment of hormone-refractory prostate cancer (HRPC) is difficult, a single-agent weekly dose of docetaxel has been reported as a promising regimen for patients with HRPC. The...
Miyazaki, Jun, Kawai, Koji, Hayashi, Hitoshi, Onozawa, Mizuki, Tsukamoto, Sadamu, Miyanaga, Naoto, ...
Background: Combination chemotherapy of methotrexate, actinomycin D and cisplatin (MAP) is reported to be effective against gestational choriocarcinoma. Methods: Eight patients with metastatic...
Kawai, Koji, Miyazaki, Jun, Tsukamoto, Sadamu, Hinotsu, Shiro, Hattori, Kazunori, Shimazui, Toru, ...
Background: Paclitaxel, ifosfamide and cisplatin (TIP) has been tested with successful results on metastatic testicular cancer in Western countries. Because paclitaxel, the key drug of this regimen,...
A new in vivo model for studying invasion and metastasis of rat and human bladder carcinomas (1993)
Kameyama, Shuji, Kawamata, Hitoshi, Kawai, Koji, Oyasu, Ryoichi
The biological potential of tumor cells is best evaluated at the organ site orthotopic to the tumor cells.Recent studies have documented site-specific differences in the potential of tumor cell...